Edward Kaye

Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) plunged more than 10 percent on Monday and hit a new 52-week low of $10.60 after the company received a notification from the U.S. Food and Drug Administration. The FDA told Sarepta Therapeutics that it requires additional time to complete its...